|
25.5 x 17 cm, 300 dpi, 1362 KB
By combining the use of biomarkers (specific molecules
or cells which can be measured as an indicator of
biological function) and advanced non-invasive medical
imaging technologies, scientists from Organon and
Philips will jointly study the effects of psychiatric
drugs in the brain at the molecular level.
Photo: Philips
|
|